The bioimaging platform enables a deep understanding of biological processes — from the spatial organization of tissue to the atomic structure of individual molecules. Using state-of-the-art imaging techniques, including super-resolution microscopy, cryo-electron microscopy, and high-multiplex antibody-based proteome imaging, as well as AI-assisted image analysis, the platform provides precise insights into disease-relevant mechanisms and drug effects. It supports the development of new therapeutic approaches—from target structure identification and molecular structural analyses to automated high-throughput screening.
Core Expertise:
- High-throughput imaging and super-resolution microscopy
- Automation of high- and ultrahigh-resolution microscopy techniques (super-resolution microscopy)
- Establishment of modern staining protocols for characterizing cellular structures
- Innovative image analysis using state-of-the-art deep learning approaches
- High-multiplex antibody-based proteome imaging
- Cryo-electron microscopy and high-precision image processing
Objectives/Services:
- Structural analysis of cells and organelles in patient cells and disease models
- Microscopy-based high-throughput assays for compound screening
- Quantitative analysis of cellular neighborhoods
- Highly sensitive analysis of drug effects
- Molecular structure determination of drug–protein and antibody–protein complexes
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP